메뉴 건너뛰기




Volumn 16, Issue 1, 2014, Pages 85-94

Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers

Author keywords

Lapachone; DCE MRI; EMMPRIN; FDG PET CT; Gemcitabine; Pancreatic cancer

Indexed keywords

ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, CD147; CELL LINE, TUMOR; DEOXYCYTIDINE; DEOXYGLUCOSE; DRUG DELIVERY SYSTEMS; FEMALE; MICE; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TUMOR BURDEN;

EID: 84895072728     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0665-4     Document Type: Article
Times cited : (10)

References (35)
  • 1
    • 8244254377 scopus 로고    scopus 로고
    • Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
    • 1:CAS:528:DyaK2sXlsFKksLY%3D 9196156
    • Burris HA III, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403-2413
    • (1997) J Clin Oncol , vol.15 , pp. 2403-2413
    • Burris III, H.A.1    Moore, M.J.2    Andersen, J.3
  • 2
    • 33845953092 scopus 로고    scopus 로고
    • Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair
    • 1:CAS:528:DC%2BD28XhtFegsbrJ 16920718 10.1074/jbc.M603678200
    • Bentle MS, Reinicke KE, Bey EA, Spitz DR, Boothman DA (2006) Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair. J Biol Chem 281:33684-33696
    • (2006) J Biol Chem , vol.281 , pp. 33684-33696
    • Bentle, M.S.1    Reinicke, K.E.2    Bey, E.A.3    Spitz, D.R.4    Boothman, D.A.5
  • 3
    • 34547481318 scopus 로고    scopus 로고
    • An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone
    • 1:CAS:528:DC%2BD2sXotVakt74%3D 1913860 17609380 10.1073/pnas.0702176104
    • Bey EA, Bentle MS, Reinicke KE et al (2007) An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci U S A 104:11832-11837
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 11832-11837
    • Bey, E.A.1    Bentle, M.S.2    Reinicke, K.E.3
  • 4
    • 0035374621 scopus 로고    scopus 로고
    • Calcium is a key signaling molecule in beta-lapachone-mediated cell death
    • 1:CAS:528:DC%2BD3MXkt12rs7w%3D 11279125 10.1074/jbc.M100730200
    • Tagliarino C, Pink JJ, Dubyak GR, Nieminen AL, Boothman DA (2001) Calcium is a key signaling molecule in beta-lapachone-mediated cell death. J Biol Chem 276:19150-19159
    • (2001) J Biol Chem , vol.276 , pp. 19150-19159
    • Tagliarino, C.1    Pink, J.J.2    Dubyak, G.R.3    Nieminen, A.L.4    Boothman, D.A.5
  • 5
    • 0037978371 scopus 로고
    • Inhibition of radiation-induced neoplastic transformation by beta-lapachone
    • 1:CAS:528:DyaL1MXksleqtrk%3D 297536 2740334 10.1073/pnas.86.13.4963
    • Boothman DA, Pardee AB (1989) Inhibition of radiation-induced neoplastic transformation by beta-lapachone. Proc Natl Acad Sci U S A 86:4963-4967
    • (1989) Proc Natl Acad Sci U S A , vol.86 , pp. 4963-4967
    • Boothman, D.A.1    Pardee, A.B.2
  • 6
    • 33748485131 scopus 로고    scopus 로고
    • High incidence of EMMPRIN expression in human tumors
    • 1:CAS:528:DC%2BD28Xps1Sns7s%3D 16721788 10.1002/ijc.22062
    • Riethdorf S, Reimers N, Assmann V et al (2006) High incidence of EMMPRIN expression in human tumors. Int J Cancer 119:1800-1810
    • (2006) Int J Cancer , vol.119 , pp. 1800-1810
    • Riethdorf, S.1    Reimers, N.2    Assmann, V.3
  • 7
    • 0036943814 scopus 로고    scopus 로고
    • EMMPRIN-mediated MMP regulation in tumor and endothelial cells
    • 1:CAS:528:DC%2BD38Xpt1KqtbY%3D 12553375 10.1023/A:1021350718226
    • Caudroy S, Polette M, Nawrocki-Raby B et al (2002) EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis 19:697-702
    • (2002) Clin Exp Metastasis , vol.19 , pp. 697-702
    • Caudroy, S.1    Polette, M.2    Nawrocki-Raby, B.3
  • 8
    • 33744962429 scopus 로고    scopus 로고
    • Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium
    • 1:CAS:528:DC%2BD28XlvVCgt7w%3D 16522689 10.1210/jc.2005-0601
    • Braundmeier AG, Fazleabas AT, Lessey BA, Guo H, Toole BP, Nowak RA (2006) Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium. J Clin Endocrinol Metab 91:2358-2365
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 2358-2365
    • Braundmeier, A.G.1    Fazleabas, A.T.2    Lessey, B.A.3    Guo, H.4    Toole, B.P.5    Nowak, R.A.6
  • 9
    • 0033998456 scopus 로고    scopus 로고
    • Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: Correlation with invasive growth of breast cancer
    • 1:STN:280:DC%2BD3c7is1Cgsw%3D%3D 10658069 10.1007/s002689910053
    • Dalberg K, Eriksson E, Enberg U, Kjellman M, Backdahl M (2000) Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. World J Surg 24:334-340
    • (2000) World J Surg , vol.24 , pp. 334-340
    • Dalberg, K.1    Eriksson, E.2    Enberg, U.3    Kjellman, M.4    Backdahl, M.5
  • 10
    • 0033991191 scopus 로고    scopus 로고
    • Role of MT-MMPs and MMP-2 in pancreatic cancer progression
    • 1:CAS:528:DC%2BD3cXhsVaitQ%3D%3D 10585576 10.1002/(SICI)1097- 0215(20000101)85:1<14: AID-IJC3>3.0.CO;2-O
    • Ellenrieder V, Alber B, Lacher U et al (2000) Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int J Cancer 85:14-20
    • (2000) Int J Cancer , vol.85 , pp. 14-20
    • Ellenrieder, V.1    Alber, B.2    Lacher, U.3
  • 11
    • 76249112702 scopus 로고    scopus 로고
    • EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2
    • 1:CAS:528:DC%2BC3cXhtFeisA%3D%3D 19837976 10.1182/blood-2009-04-217380
    • Bougatef F, Quemener C, Kellouche S et al (2009) EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. Blood 114:5547-5556
    • (2009) Blood , vol.114 , pp. 5547-5556
    • Bougatef, F.1    Quemener, C.2    Kellouche, S.3
  • 12
    • 0034796595 scopus 로고    scopus 로고
    • Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
    • 1:CAS:528:DC%2BD3MXmvFOmsrc%3D 11533692 10.1038/nm0901-987
    • Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7:987-989
    • (2001) Nat Med , vol.7 , pp. 987-989
    • Jain, R.K.1
  • 13
    • 79955003047 scopus 로고    scopus 로고
    • Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging
    • 1:CAS:528:DC%2BC3MXovFOiur4%3D 21496446
    • Kim H, Folks KD, Guo L et al (2011) Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging. Mol Imaging 10:153-167
    • (2011) Mol Imaging , vol.10 , pp. 153-167
    • Kim, H.1    Folks, K.D.2    Guo, L.3
  • 14
    • 34248594167 scopus 로고    scopus 로고
    • Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts
    • 17401098 10.2967/jnumed.106.036608
    • Dandekar M, Tseng JR, Gambhir SS (2007) Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts. J Nucl Med 48:602-607
    • (2007) J Nucl Med , vol.48 , pp. 602-607
    • Dandekar, M.1    Tseng, J.R.2    Gambhir, S.S.3
  • 15
    • 0346562891 scopus 로고    scopus 로고
    • Positron emission tomography using 2-deoxy-2-[18F]-fluoro-d-glucose for response monitoring in locally advanced gastroesophageal cancer; A comparison of different analytical methods
    • 14630513 10.1016/j.mibio.2003.09.007
    • Kroep JR, Van Groeningen CJ, Cuesta MA et al (2003) Positron emission tomography using 2-deoxy-2-[18F]-fluoro-d-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods. Mol Imaging Biol 5:337-346
    • (2003) Mol Imaging Biol , vol.5 , pp. 337-346
    • Kroep, J.R.1    Van Groeningen, C.J.2    Cuesta, M.A.3
  • 16
    • 20244376908 scopus 로고    scopus 로고
    • Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
    • 1:CAS:528:DC%2BD2MXjtlejsbY%3D 15837727 10.1158/1078-0432.CCR-04-2626
    • Kelloff GJ, Hoffman JM, Johnson B et al (2005) Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 11:2785-2808
    • (2005) Clin Cancer Res , vol.11 , pp. 2785-2808
    • Kelloff, G.J.1    Hoffman, J.M.2    Johnson, B.3
  • 17
    • 79551595372 scopus 로고    scopus 로고
    • DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy
    • 20383593 10.1007/s11307-010-0320-2
    • Kim H, Folks KD, Guo L et al (2011) DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy. Mol Imaging Biol 13:94-103
    • (2011) Mol Imaging Biol , vol.13 , pp. 94-103
    • Kim, H.1    Folks, K.D.2    Guo, L.3
  • 18
    • 0031969264 scopus 로고    scopus 로고
    • Angiogenesis and tumor metastasis
    • 1:CAS:528:DyaK1cXhtFKqt70%3D 9509272 10.1146/annurev.med.49.1.407
    • Zetter BR (1998) Angiogenesis and tumor metastasis. Annu Rev Med 49:407-424
    • (1998) Annu Rev Med , vol.49 , pp. 407-424
    • Zetter, B.R.1
  • 19
    • 84861479808 scopus 로고    scopus 로고
    • (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts
    • 3594775 21494920 10.1007/s11307-011-0491-5 MIB: the official publication of the Academy of Molecular Imaging
    • Shah N, Zhai G, Knowles JA et al (2012) (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Mol Imaging Biol 14:237-244, MIB: the official publication of the Academy of Molecular Imaging
    • (2012) Mol Imaging Biol , vol.14 , pp. 237-244
    • Shah, N.1    Zhai, G.2    Knowles, J.A.3
  • 20
    • 80052532390 scopus 로고    scopus 로고
    • Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy
    • 1:CAS:528:DC%2BC3MXhtVyltbbO 3587034 21730821 10.1097/CAD. 0b013e328349311e
    • Kim H, Zhai G, Liu Z et al (2011) Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anti-Cancer Drugs 22:864-874
    • (2011) Anti-Cancer Drugs , vol.22 , pp. 864-874
    • Kim, H.1    Zhai, G.2    Liu, Z.3
  • 21
    • 51549089094 scopus 로고    scopus 로고
    • Breast tumor xenografts: Diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody
    • 18710978 10.1148/radiol.2483071740
    • Kim H, Morgan DE, Zeng H et al (2008) Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology 248:844-851
    • (2008) Radiology , vol.248 , pp. 844-851
    • Kim, H.1    Morgan, D.E.2    Zeng, H.3
  • 23
    • 0022107328 scopus 로고
    • Repeated-measures analysis of variance in developmental research: Selected issues
    • 1:STN:280:DyaL28%2FgtlOisw%3D%3D 4042744 10.2307/1130092
    • Hertzog C, Rovine M (1985) Repeated-measures analysis of variance in developmental research: selected issues. Child Dev 56:787-809
    • (1985) Child Dev , vol.56 , pp. 787-809
    • Hertzog, C.1    Rovine, M.2
  • 24
    • 84952503562 scopus 로고
    • Thirteen ways to look at the correlation coefficient
    • 10.2307/2685263
    • Rodgers JL, Nicewander WA (1988) Thirteen ways to look at the correlation coefficient. Am Stat 42:59-66
    • (1988) Am Stat , vol.42 , pp. 59-66
    • Rodgers, J.L.1    Nicewander, W.A.2
  • 25
    • 84863156565 scopus 로고    scopus 로고
    • Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma
    • 1:CAS:528:DC%2BC38XitFWlu70%3D 3277644 22203731 10.1158/1535-7163.MCT-11- 0581
    • Kim H, Zhai G, Samuel SL et al (2012) Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma. Mol Cancer Ther 11:405-415
    • (2012) Mol Cancer Ther , vol.11 , pp. 405-415
    • Kim, H.1    Zhai, G.2    Samuel, S.L.3
  • 27
    • 20444479863 scopus 로고    scopus 로고
    • Differential diagnosis of pancreatic tumors using ultrasound contrast imaging
    • 15942718 10.1007/s00535-005-1578-z
    • Sofuni A, Iijima H, Moriyasu F et al (2005) Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 40:518-525
    • (2005) J Gastroenterol , vol.40 , pp. 518-525
    • Sofuni, A.1    Iijima, H.2    Moriyasu, F.3
  • 28
    • 1642266635 scopus 로고    scopus 로고
    • Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma
    • 1:STN:280:DC%2BD1c7ntlyhtw%3D%3D 2020655 18333037 10.1080/ 13651820310017093 The Official Journal of the International Hepato Pancreato Biliary Association
    • Andersson R, Vagianos CE, Williamson RC (2004) Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma. HPB 6:5-12, The Official Journal of the International Hepato Pancreato Biliary Association
    • (2004) HPB , vol.6 , pp. 5-12
    • Andersson, R.1    Vagianos, C.E.2    Williamson, R.C.3
  • 29
    • 22844445593 scopus 로고    scopus 로고
    • Locally advanced pancreatic cancer
    • 16002845 10.1200/JCO.2005.23.911 Official Journal of the American Society of Clinical Oncology
    • Willett CG, Czito BG, Bendell JC, Ryan DP (2005) Locally advanced pancreatic cancer. J Clin Oncol 23:4538-4544, Official Journal of the American Society of Clinical Oncology
    • (2005) J Clin Oncol , vol.23 , pp. 4538-4544
    • Willett, C.G.1    Czito, B.G.2    Bendell, J.C.3    Ryan, D.P.4
  • 30
    • 33745649188 scopus 로고    scopus 로고
    • Locally advanced pancreatic cancer: Current therapeutic approach
    • 1:CAS:528:DC%2BD28XhtFGhu7vE 16794240 10.1634/theoncologist.11-6-612
    • Cardenes HR, Chiorean EG, Dewitt J, Schmidt M, Loehrer P (2006) Locally advanced pancreatic cancer: current therapeutic approach. Oncologist 11:612-623
    • (2006) Oncologist , vol.11 , pp. 612-623
    • Cardenes, H.R.1    Chiorean, E.G.2    Dewitt, J.3    Schmidt, M.4    Loehrer, P.5
  • 31
    • 84864272568 scopus 로고    scopus 로고
    • Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
    • 22517425 10.1002/jmri.23660 JMRI
    • Chang YC, Yu CJ, Chen CM et al (2012) Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin. J Magn Reson Imaging 36:387-396, JMRI
    • (2012) J Magn Reson Imaging , vol.36 , pp. 387-396
    • Chang, Y.C.1    Yu, C.J.2    Chen, C.M.3
  • 32
    • 84869866354 scopus 로고    scopus 로고
    • Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: Potential of whole tumour ROI and selective ROI analysis
    • 22944331 10.1016/j.ejrad.2012.07.022
    • Coenegrachts K, Bols A, Haspeslagh M, Rigauts H (2012) Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: potential of whole tumour ROI and selective ROI analysis. Eur J Radiol 81:3870-3876
    • (2012) Eur J Radiol , vol.81 , pp. 3870-3876
    • Coenegrachts, K.1    Bols, A.2    Haspeslagh, M.3    Rigauts, H.4
  • 33
    • 77951222660 scopus 로고    scopus 로고
    • Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI
    • 19727758 10.1007/s00330-009-1556-6
    • Zwick S, Brix G, Tofts PS et al (2010) Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI. Eur Radiol 20:432-442
    • (2010) Eur Radiol , vol.20 , pp. 432-442
    • Zwick, S.1    Brix, G.2    Tofts, P.S.3
  • 34
    • 84874293321 scopus 로고    scopus 로고
    • Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions
    • 23220897 10.1148/radiol.12120278
    • Heye T, Davenport MS, Horvath JJ et al (2013) Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions. Radiology 266:801-811
    • (2013) Radiology , vol.266 , pp. 801-811
    • Heye, T.1    Davenport, M.S.2    Horvath, J.J.3
  • 35
    • 84862566809 scopus 로고    scopus 로고
    • An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis
    • 1:CAS:528:DC%2BC38Xos1yisr4%3D 22532167 10.1158/0008-5472.CAN-11-3135
    • Huang X, Dong Y, Bey EA et al (2012) An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis. Cancer Res 72:3038-3047
    • (2012) Cancer Res , vol.72 , pp. 3038-3047
    • Huang, X.1    Dong, Y.2    Bey, E.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.